GPR65 as a Laryngeal Cancer Risk Gene Identified through Single-Cell Transcriptomics, Mendelian Randomization Analysis, and Experimental Validation
The present findings showed that highly expressed GPR65 was a tumor-promoting gene in laryngeal cancer, showing its clinical value as a potential therapeutic target.
Authors
- Haosheng Ni (ORCID: https://orcid.org/0000-0002-8491-6707)
- Yuan‐Fei Zhou (ORCID: https://orcid.org/0009-0002-6374-9222)
- Bin Zhao (ORCID: https://orcid.org/0000-0001-7065-2416)
- Shu-Zheng Wang
- Qiao Mao (ORCID: https://orcid.org/0000-0001-7938-6660)
- Hao Wu (ORCID: https://orcid.org/0000-0003-4694-7657)
- Zhenxin Zhang
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- Anti-Cancer Agents in Medicinal Chemistry
- Published
- 2025-10-15
- DOI
- https://doi.org/10.2174/0118715206414176250905114930
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00